title: Neoral conversion in stable thoracic transplant patients leads to dose reduction.
authors.affiliation: Division of Cardiothoracic Surgery, University of Pittsburgh Medical Center, PA 15213, USA.
authors.forename: D B
authors.initials: DB
authors.lastname: Zaldonis
authors.forename: R J
authors.initials: RJ
authors.lastname: Keenan
authors.forename: S M
authors.initials: SM
authors.lastname: Pham
authors.forename: R L
authors.initials: RL
authors.lastname: Kormos
authors.forename: B P
authors.initials: BP
authors.lastname: Griffith
mesh_terms: D000284:Administration, Oral; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D016027:Heart Transplantation / Q000276:immunology*; D016041:Heart-Lung Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016040:Lung Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine